Skip to main content
Clinical Trials/ACTRN12619001146189
ACTRN12619001146189
Recruiting
未知

Effectiveness of Lee Silverman Voice Treatment (LSVT LOUD) on voice, swallowing and cough function in Parkinson’s Disease: A randomized controlled trial

niversity of Auckland0 sites120 target enrollmentAugust 16, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Parkinson's disease
Sponsor
niversity of Auckland
Enrollment
120
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 16, 2019
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Auckland

Eligibility Criteria

Inclusion Criteria

  • 1\)Individuals with PD who meet the inclusion criteria for LSVT LOUD (\*see below).
  • 2\)Ability to attend the full programme (16 therapy session) and follow up reviews, swallow and cough studies.
  • 3\)Ability to complete self\-reported questionnaires (PDQ\-8, VHI\-10, EAT\-10, HARQ, and CETI\-M) by written completion of the questionnaires or oral report. Carer support can be provided.
  • \*Criteria for Lee Silverman Voice Therapy (LSVT LOUD)
  • a)Motivated and able to commit to intensive therapy
  • b)Adequate hearing
  • c)Adequate cognition and memory
  • d)Positive results on stimulability testing suggesting likely response to treatment (is the people able to improve loudness and quality? Can they achieve sustained vowel phonation, high and low pitch slide on ‘ah’ and functional phrases?)
  • e)Socially active and keen to increase participation
  • f)Otolaryngologist assessment reporting no contraindications to treatment.

Exclusion Criteria

  • 1\)People with PD without voice dysfunction.
  • 2\)Diagnosis of atypical PD.
  • 3\)Speech or voice disorder unrelated to PD.
  • 4\)Vocal pathology requiring alternative treatment e.g. surgery
  • 5\)History of neurosurgical treatment.
  • 6\)History of laryngeal surgery or pathology.
  • 7\)Previous history of head and neck radiotherapy treatment
  • 8\)Co morbidity affecting swallowing ability eg. cerebrovascular accident, neurogenic dysphagia of other aetiology, post\-surgical dysphagia, infective dysphagia or dementia, active tumour in larynx/ oesophagus, or Zenker’s diverticulum.
  • 9\)Currently pregnant, as evidenced by a positive result on a pregnancy test if the people are within child bearing age (younger than 45 years of age).
  • 10\) Presence of a tracheotomy tube or airway obstruction necessitating a tracheotomy tube.

Outcomes

Primary Outcomes

Not specified

Similar Trials